Pay in 4 interest-free payments of $7.33 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Data was self-reported by 1,412 surveyed customers who checked in with their provider between second and third check-in
Trials in type 2 diabetes patients have shown reduced rates of heart attack and stroke, which is one of the strongest reasons to use it in that population
doi: 10.1038/s41541-019-0148-y 28 ReynissonBAlvarezBPaulSPetersBNielsenM
Moreover, DEX treatment (0.5 g/kg/h, pumping injection, before induction of anesthesia to the end of surgery) has been reported to reduce cardiac troponin I and MDA levels and to decrease the incidence of arrhythmias in patients undergoing cardiac valve replacement [234, 235]
Public health systems in developed markets are establishing structured access pathways based on BMI thresholds combined with cardiovascular or metabolic comorbidities
